Moderate hyperbilirubinemia improves renal hemodynamics in ANG II-dependent hypertension
Authors:
- 1 October 2010
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 299 (4) , R1044-R1049
Abstract
We have previously demonstrated that moderate hyperbilirubinemia decreases blood pressure in ANG II-dependent hypertension through mechanisms that decrease oxidative stress and increase nitric oxide levels. Since decreases in renal hemodynamics play an important role in mediating the hypertensive actions of ANG II, the goal of the present study was to examine the effect of moderate hyperbilirubinemia on glomerular filtration rate (GFR) and renal blood flow (RBF) in a mouse model of ANG II hypertension. Mice were made moderately hyperbilirubinemic by two methods: indinavir or specific morpholino antisense oligonucleotides against UGT1A1, which is the enzyme responsible for the conjugation of bilirubin in the liver. GFR and RBF were measured in mice after implantation of an osmotic minipump delivering ANG II at a rate of 1 μg·kg−1·min−1. GFR was measured by continuous infusion of I125-labeled iothalamate on days 5 and 6 of ANG II infusion in conscious mice. RBF was measured on day 7 of ANG II infusion in anesthetized mice. Blood levels of unconjugated bilirubin were significantly increased in mice treated with indinavir or anti-UGT1A1 ( P = 0.002). ANG II decreased GFR by 33% of control ( n = 9, P = 0.004), and this was normalized by moderate hyperbilirubinemia ( n = 6). Next, we examined the effect of moderate hyperbilirubinemia on RBF in ANG II-infused mice. ANG II infusion significantly decreased RBF by 22% ( P = 0.037) of control, and this decrease was normalized by moderate hyperbilirubinemia ( n = 6). These results indicate that improvement of renal hemodynamics may be one mechanism by which moderate hyperbilirubinemia lowers blood pressure in this model.Keywords
This publication has 39 references indexed in Scilit:
- Blood pressure and renal blow flow responses in heme oxygenase-2 knockout miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Enhanced Distal Nephron Sodium Reabsorption in Chronic Angiotensin II–Infused MiceHypertension, 2009
- The Bilirubin Level is Negatively Correlated with the Incidence of Hypertension in Normotensive Korean PopulationJournal of Korean Medical Science, 2009
- The Mildly Elevated Serum Bilirubin Level is Negatively Associated with the Incidence of End Stage Renal Disease in Patients with IgA NephropathyJournal of Korean Medical Science, 2009
- Heme Oxygenase-1 Induction Does Not Improve Vascular Relaxation in Angiotensin II Hypertensive MiceAmerican Journal of Hypertension, 2008
- Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidneyProceedings of the National Academy of Sciences, 2006
- Fenofibrate Prevents the Development of Angiotensin II–Dependent Hypertension in MiceHypertension, 2005
- Heme Oxygenase-1 Gene Expression Modulates Angiotensin II–Induced Increase in Blood PressureHypertension, 2004
- Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1996